Our study explores the complex dynamics of the integrated stress response (ISR) axis, highlighting PIM2 kinase's critical role and its interaction with the BCL2 protein family, uncovering key mechanisms of cell survival and tumor progression. Elevated PIM2 expression, a marker of various cancers, often correlates with disease aggressiveness. Using a model of normal and malignant plasma cells, we show that inhibiting PIM2 kinase inhibits phosphorylated BAD production and activates ISR-mediated NOXA expression. This shift towards MCL1 dependence underscores the synergy achieved through combined PIM/MCL1 inhibition, driven largely by ISR-mediated NOXA expression. In mouse xenograft models, dual targeting of PIM2 and MCL1 effectively controls tumor growth-a response reversed by ISR-specific inhibition and upregulation of genes linked to tumor cell dissemination. This work elucidates the molecular intricacies of PIM2 inhibition and its implications for cancer therapy, especially in tumors with elevated PIM2 expression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11696207PMC
http://dx.doi.org/10.1038/s41467-024-55572-5DOI Listing

Publication Analysis

Top Keywords

noxa expression
12
pim2 inhibition
8
plasma cells
8
integrated stress
8
elevated pim2
8
pim2 expression
8
isr-mediated noxa
8
pim2
7
expression
5
inhibition promotes
4

Similar Publications

Our study explores the complex dynamics of the integrated stress response (ISR) axis, highlighting PIM2 kinase's critical role and its interaction with the BCL2 protein family, uncovering key mechanisms of cell survival and tumor progression. Elevated PIM2 expression, a marker of various cancers, often correlates with disease aggressiveness. Using a model of normal and malignant plasma cells, we show that inhibiting PIM2 kinase inhibits phosphorylated BAD production and activates ISR-mediated NOXA expression.

View Article and Find Full Text PDF
Article Synopsis
  • Dioscin is a natural steroidal saponin that shows antitumor effects by triggering apoptosis in various cancers, particularly through the Noxa protein.
  • The study found that Dioscin enhances Noxa expression by reducing BMI1 levels, leading to increased tumor cell death in oral squamous cell carcinoma (OSCC).
  • Additionally, Dioscin demonstrates effective tumor suppression in animal models, offering potential new strategies for treating OSCC.
View Article and Find Full Text PDF

Background And Objective: Prostate cancer is a major cause of cancer-related morbidity and mortality in men globally. The pathogenesis involves complex interactions between genetic mutations and environmental factors, activating multiple signaling pathways, especially Wnt/β-catenin, PI3K/Akt, and NF-κB pathways. Tumor suppressor genes and are key inhibitors of these pathways, crucial in suppressing tumor growth and metastasis.

View Article and Find Full Text PDF

NmrA homologs have been reported as conserved regulators of the nitrogen metabolite repression (NMR) in various fungi. Here, we identified a NmrA homolog in and reported its functions in nitrogen utilization, growth and development, and pathogenesis. VdNmrA interacts with AreA protein and regulates the expression of a typical NCR target, the formamidase gene.

View Article and Find Full Text PDF
Article Synopsis
  • The Japanese encephalitis virus (JEV) is a major cause of viral encephalitis in Asia and triggers cell apoptosis through mechanisms that are not fully understood.
  • In this study, researchers used CRISPR/Cas9 to knockout the BAX gene in PK-15 cells, which decreased JEV proliferation by nearly 40%, while overexpressing BAX had the opposite effect.
  • JEV infection led to significant upregulation of various pro-apoptotic factors and mitochondrial damage, accelerating apoptosis, but knocking out BAX mitigated these effects, providing insights into JEV's pathogenic mechanisms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!